Episode 23

Ep. 23 : Group Administration of Psychedelics: An Interview with Chris Stauffer

Published on: 23rd June, 2022

Dr. Chris Stauffer talks about his research investigating the use of group-administered psilocybin and MDMA. The advantages of group administration are discussed, including the opportunity to increase social connection and deepen capacities to be vulnerable with others. Dr. Stauffer also highlights how group psychedelic-assisted therapy needs to be adapted to the identities of the participants, sharing about his experiences in working with the veteran population and a study with transgender and gender non-conforming participants. Chris also discusses his work on oxytocin and how that influences the way the thinks about increased social connection as a process of change involved in psychedelic-assisted therapy.

Mentioned in the show:

Rat Park Study: https://www.psychiatrictimes.com/view/what-does-rat-park-teach-us-about-addiction

MDMA and Critical Periods: https://hub.jhu.edu/2019/04/04/mdma-opens-critical-period-for-social-behavior/

https://www.chrisstauffermd.com/

Next Episode All Episodes Previous Episode

Stay up to date!

Stay up to date!

Get new episode alerts straight to your inbox every other Monday. Join a growing community of therapists, researchers and other folks interested in growth and healing via the wise and intentional use of psychedelic medicine.

Thanks for subscribing to Altered States of Context! Expect a new episode every other Monday in your inbox, with discussions of psychedelic integration, useful conceptualizations of potential therapeutic mechanisms, and interviews with leaders in the field of psychedelic medicine.

Listen for free

RSS Feed

Show artwork for Altered States of Context

About the Podcast

Altered States of Context

A Podcast about Psychedelics, Science and Psychotherapy

Brian Pilecki and Nathan Gates, two therapists and long-time psychedelic advocates explore the uneasy fit between a medicalized view of individual mental illness and a psychedelic view of suffering and change.

We'll also explore many of the possibilities, opportunities and pitfalls that emerge from this union.

In addition, we'll keep it weird, and talk about some of the aspects of psychedelic experiencing that make it so interesting, fun, and transformative.

This will hold interests for anyone interested in behavior change, cultural trends, and for professionals eager to explore how psychedelics are poised to change many of our therapeutic orientations and approaches.

About your hosts

Nathan Gates

Nathan is a licensed psychotherapist and co-host of Altered States of Context, a podcast about psychedelics, science and psychotherapy. In addition, he serves as president of the board for the Illinois Psychedelic Society and is a board advisor for Entheo Il, a group dedicated to the successful passage of Illinois HB1, the Compassionate Use and Research of Entheogens act. He also practices regenerative ranching and writes from his family's farm in rural west-central Illinois. He is a frequent guest and guest host for the Doomer Optimism podcast, a collective podcast dedicated to promotive creative and humane ways to engage with our social and environmental problems with creativity, hope, and good stewardship.

Brian Pilecki

Dr. Brian Pilecki is a clinical psychologist at the Portland Psychotherapy Clinic that specializes in the treatment of anxiety disorders (OCD, generalized anxiety, social anxiety, panic disorder), trauma and PTSD, and matters related to the use of psychedelics. He completed a post-doctoral fellowship at The Warren Alpert Medical School of Brown University and practices from an orientation based in Acceptance and Commitment Therapy (ACT). Brian also has extensive experience in the areas of mindfulness and meditation, and incorporates them into his therapy with clients. He is an active researcher and has published on topics such as anxiety disorders, mindfulness, and the relationship between theory and practice in psychotherapy. At Portland Psychotherapy, Brian is also involved in research in the use of psychedelics for the treatment of mental health problems.